PEY3 RANIBIZUMAB (LUCENTIS®) IS A COST-EFFECTIVE TREATMENT OF AGE-RELATED MACULA DEGENERATION (AMD) IN THE GERMAN HEALTH CARE SYSTEM

Nov 1, 2007, 00:00 AM
10.1016/S1098-3015(10)65237-0
https://www.valueinhealthjournal.com/article/S1098-3015(10)65237-0/fulltext
Section Title :
Section Order : 395
First Page :
https://www.valueinhealthjournal.com/action/showCitFormats?pii=S1098-3015(10)65237-0&doi=10.1016/S1098-3015(10)65237-0
HEOR Topics :
Tags :
Regions :